Viridian Therapeutics Inc (NQ: VRDN )
15.19
+0.14
(+0.93%)
Streaming Delayed Price
Updated: 12:30 PM EDT, Aug 26, 2024
Add to My Watchlist
Headline News about Viridian Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Decoding 6 Analyst Evaluations For Viridian Therapeutics
August 15, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/30/Healthcare-Consulting.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/10/stock-biogen-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Expert Ratings For Viridian Therapeutics
July 16, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2024/01/hand-purple-growth-stocks-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Unveiling 4 Analyst Insights On Viridian Therapeutics
March 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Navigating 6 Analyst Ratings For Viridian Therapeutics
February 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/05/bank-lending-capital-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/covid-19-5169689.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/18/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Viridian Therapeutics
December 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Where Viridian Therapeutics Stands With Analysts
November 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/30/western_digital_-_logo_0.jpg?width=1200&height=800&fit=crop)
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
October 30, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Viridian Therapeutics
September 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
9 Analysts Have This to Say About Viridian Therapeutics
August 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/10/global_payments_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/739957/a-doctor-looking-at-a-tablet-with-another-person.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/11/image21.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/739299/optometrist-testing-patients-vision.jpg)
![](https://www.investors.com/wp-content/uploads/2018/10/Stock-DrugSpill-02-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.